ReShape Lifesciences Inc.

NASDAQ:RSLS 4:00:00 PM EDT

0.44

-0.08 (-15.38%)

7:59:51 PM EDT: $0.48 +0.04 (+9.09%)

Market Cap (Intraday)	1.52M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$2.4 Million
Adjusted EPS	-$1.20

See more estimates

10-Day MA	$0.61
50-Day MA	$1.06
200-Day MA	$3.31

See more pivots

ReShape Lifesciences Inc. Stock, NASDAQ:RSLS

1001 Calle Amanecer, San Clemente, California 92673

United States of America

Phone: +1.949.429.6680

Number of Employees: 40

http://www.reshapelifesciences.com

Description

ReShape Lifesciences, Inc. is a medical device company, which focuses on technology to treat obesity and metabolic diseases. Its portfolio includes the Lap-Band Adjustable Gastric Banding System, ReShape Marketplace, Obalon Balloon System, ReShape Vest, and Diabetes Bloc-Stim Neuromodulation device. It operates though the United States, Australia, Europe, and Rest of World geographical segments. The company was founded in December 2002 and is headquartered in San Clemente, CA.